Acquired Pure Red Cell Aplasia
3 clinical trials · Condition
◉ Watch Acquired Pure Red Cell Aplasia
| Record | Firm | Date |
|---|---|---|
| Linperlisib in the Treatment of aPRCA (NCT07031115) | Peking Union Medical College Hospital | 2025-09-01 |
| MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure. (NCT06412497) | Masonic Cancer Center, University of Minnesota | 2024-06-05 |
| Bortezomib Plus Dexamethasone for Acquired Pure Red Cell Aplasia Failure or Relapse After First-line Treatment (NCT04423367) | Institute of Hematology & Blood Diseases Hospital, China | 2020-09-13 |
Track Acquired Pure Red Cell Aplasia automatically
Every clearance here is in the API, with alerts when new ones post.